Arena Pharmaceuticals, Inc. (ARNA): What Do The Smartest Investors Think?

Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a safe stock to buy now? Hedge funds are turning bullish. The number of long hedge fund bets increased by 2 lately.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)In the financial world, there are tons of indicators investors can use to watch their holdings. Some of the most under-the-radar are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best fund managers can outperform the market by a very impressive margin (see just how much).

Just as integral, bullish insider trading sentiment is a second way to parse down the investments you’re interested in. There are lots of motivations for an upper level exec to sell shares of his or her company, but just one, very simple reason why they would buy. Several academic studies have demonstrated the valuable potential of this method if “monkeys” know where to look (learn more here).

Keeping this in mind, it’s important to take a glance at the key action encompassing Arena Pharmaceuticals, Inc. (NASDAQ:ARNA).

How have hedgies been trading Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)?

At the end of the first quarter, a total of 13 of the hedge funds we track were long in this stock, a change of 18% from the first quarter. With the smart money’s sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their holdings significantly.

When looking at the hedgies we track, James E. Flynn’s Deerfield Management had the largest position in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), worth close to $43.9 million, accounting for 2.6% of its total 13F portfolio. Sitting at the No. 2 spot is Peter Rathjens, Bruce Clarke and John Campbell of Arrowstreet Capital, with a $7.7 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Other peers with similar optimism include Daniel Gold’s QVT Financial, and Robert Pohly’s Samlyn Capital.

With a general bullishness amongst the heavyweights, some big names were breaking ground themselves. Arrowstreet Capital, managed by Peter Rathjens, Bruce Clarke and John Campbell, created the most outsized position in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA). Arrowstreet Capital had 7.7 million invested in the company at the end of the quarter. Robert Pohly’s Samlyn Capital also made a $3.6 million investment in the stock during the quarter. The other funds with new positions in the stock are Daniel S. Och’s OZ Management and Gabe Hoffman’s Accipiter Capital Management.

How have insiders been trading Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)?

Insider trading activity, especially when it’s bullish, is particularly usable when the company in focus has experienced transactions within the past half-year. Over the latest 180-day time frame, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has experienced zero unique insiders purchasing, and 2 insider sales (see the details of insider trades here).

With the results shown by Insider Monkey’s tactics, everyday investors must always pay attention to hedge fund and insider trading sentiment, and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) applies perfectly to this mantra.

Click here to learn why you should track hedge funds

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Top 10 Most Expensive Luxury Cars in the World – 2014

Killer Small Business Ideas

The 50 Best Personal Finance Blogs

Most Expensive Apartments in New York City

Bloodiest UFC Fights Ever Fought

Most Expensive Rum Brands in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!